Skip to main content

Endo Int'l Plc(ENDP-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low0.3600
Day High0.4040
Open:0.3901
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest News

New Drug Filing for Cenobamate Accepted for Review in Canada and Israel
PR Newswire - Tue Aug 9, 8:00AM CDT
PR Newswire
Tue Aug 9, 8:00AM CDT
/PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd. announced that Health Canada has accepted Paladin Labs Inc.'s filing of a New Drug Submission (NDS) for...
ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS
Newswire.ca - Tue Aug 9, 7:45AM CDT
Newswire.ca
Tue Aug 9, 7:45AM CDT
/CNW/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022. SECOND-QUARTER FINANCIAL...
ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS
PR Newswire - Tue Aug 9, 7:45AM CDT
PR Newswire
Tue Aug 9, 7:45AM CDT
/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022. SECOND-QUARTER FINANCIAL...

Latest Articles